General Information of the Compound
Compound ID |
CP0326120
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
N-[[(2S,4S)-2-benzhydryl-1,3-dioxolan-4-yl]methyl]-2-(2-methoxyphenoxy)ethanamine;oxalic acid
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C28H31NO8
|
||||||||||||||||||
Molecular Weight |
509.555
|
||||||||||||||||||
Canonical SMILES |
OC(=O)C(O)=O.COc1ccccc1OCCNC[C@H]1CO[C@@H](O1)C(c1ccccc1)c1ccccc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C26H29NO4.C2H2O4/c1-28-23-14-8-9-15-24(23)29-17-16-27-18-22-19-30-26(31-22)25(20-10-4-2-5-11-20)21-12-6-3-7-13-21;3-1(4)2(5)6/h2-15,22,25-27H,16-19H2,1H3;(H,3,4)(H,5,6)/t22-,26-;/m0./s1
Show/Hide
|
||||||||||||||||||
InChIKey |
OWCHNBFFLPYCAL-QHTHEMFPSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Protein ID: PT01089, Alpha-1A adrenergic receptor
Protein ID: PT01007, Alpha-1B adrenergic receptor
Protein ID: PT01004, Alpha-1D adrenergic receptor